Tarsadia Investments

Tarsadia Investments is a private investment firm based in Newport Beach, California, with an additional office in New York. The firm specializes in providing capital and strategic support to companies across various sectors, including healthcare, financial services, real estate, life sciences, and clean technology. Tarsadia Investments focuses on identifying and fostering businesses with substantial growth potential, offering flexible support that spans from the initial idea generation stage to public ownership. Through its multi-strategy approach, the firm seeks to make impactful investments globally, contributing to the development and success of diverse enterprises.

David Browne

CFO

Mitchell Caplan

President

Mitch Caplan

President

Greg Casserly

CEO

Tushar Patel

Chairman and Founder

Gautam Patel

Managing Director

Darshan Patel

Associate

Rishi N. Reddy

Managing Director - Head of Venture and Growth

Rishi N. Reddy

Managing Director and Head of Venture and Growth

Jay Santoro

Vice President

37 past transactions

Pagos

Series A in 2023
Pagos is a company that specializes in developing a software-as-a-service (SaaS) financial platform aimed at optimizing payment processing for businesses. Founded in 2021 and based in Wilmington, Delaware, Pagos offers a data platform and API-driven micro-services that can integrate seamlessly with various payment systems. Its solutions focus on normalizing, visualizing, aggregating, and monitoring payment data, which helps companies enhance performance, increase sales, and reduce the overall costs associated with payment acceptance. Additionally, Pagos provides tools that enable merchant companies to effectively manage their payments, fostering business growth and building long-term customer relationships.

Envisics

Series C in 2023
Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, focused on designing and developing advanced holographic projection systems and computational algorithms for head-up displays and head-mounted display applications. Established in 2009, Envisics specializes in light manipulation through phase-only holography, offering high-quality image projection that enhances the in-car experience. By leveraging holography and laser-based light sources, the company aims to transform automotive displays and improve safety for drivers. Through collaborations with leading automakers and tier-one suppliers, Envisics is working to bring innovative holographic technology to the automotive sector, enabling drivers to access critical information without distraction by seamlessly overlaying data onto their field of vision.

Matterworks

Convertible Note in 2023
Matterworks is a developer of an artificial intelligence platform focused on advancing the field of metabolomics within the life sciences. The company's technology enhances analytical capabilities, allowing scientific researchers to conduct faster and more comprehensive metabolomic screenings. By facilitating the discovery and engineering processes, Matterworks aims to accelerate scientific progress and support innovation in various biological applications.

Fathom

Series B in 2022
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Jüsto

Series B in 2022
Jüsto is an online delivery-only grocery store that specializes in providing a diverse selection of products, including fruits, vegetables, meat, beauty items, and household supplies. The company focuses on delivering fresh and healthy food options directly to consumers' doorsteps, emphasizing affordability and convenience. By operating as an online supermarket, Jüsto aims to meet the needs of customers looking for quality grocery items without the necessity of visiting a physical store.

Kirilys Therapeutics

Seed Round in 2022
Kirilys is a biopharmaceutical firm. It was in the preclinical stages that were committed to enhancing the quality of life for cancer patients through the creation and enhancement of therapy regimens.

Chronus Health

Series A in 2022
Chronus Health, Inc. is a company that specializes in developing a portable diagnostic platform aimed at delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and based in Mountain View, California, the company's innovative system utilizes microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time test results. This capability allows for immediate diagnosis at the point of care, enhancing the efficiency of treatment and significantly improving patient outcomes. By enabling doctors to obtain lab results in minutes, Chronus Health facilitates timely decision-making in clinical settings.

Petal

Series D in 2022
Petal is a credit card company that is built to help people financially succeed. It aims to make credit honest, simple, and accessible. The company uses machine learning to analyze a customer’s full digital financial record—not just their credit score. Petal has pioneered cash flow underwriting, as an alternative to credit scores, to make credit more accessible, and offers a simple, modern digital experience that encourages members to build credit, avoid debt, and spend responsibly. Petal is based in New York, New York, and Richmond, Virginia. The Petal credit card is issued by WebBank, Member FDIC.

AvantStay

Series B in 2021
AvantStay, Inc. is a hospitality company founded in 2016 and based in Los Angeles, California, specializing in vacation rental homes. The company operates a next-generation platform that redefines travel and investment experiences by offering a highly curated selection of short-term rental properties tailored to guests' needs. With a portfolio exceeding 450 premier properties across more than 60 cities, AvantStay utilizes proprietary technology to facilitate seamless bookings and efficient property management. The company has established partnerships with various online travel agencies, enabling direct bookings and enhancing accessibility for travelers. AvantStay aims to provide an elevated and authentic experience for its customers while maintaining an asset under management exceeding $800 million.

Konfio

Series E in 2021
Konfio is a financial services platform based in Mexico City that focuses on providing online financial solutions for small and medium-sized enterprises (SMEs) and micro-entrepreneurs. Founded in 2013, the company offers a range of products including fixed-rate loans, working capital loans, corporate credit cards, and payment solutions, as well as life insurance and personal debt transfer services. Konfio utilizes a proprietary algorithm that leverages data and technology to assess creditworthiness, enabling access to credit for clients who have been underserved by traditional banking. By offering competitive rates and convenient services, Konfio aims to enhance the growth and productivity of SMEs in Mexico.

bolttech

Series A in 2021
Bolttech is an InsurTech company that specializes in an AI-driven point-of-sale insurance platform, designed to create a technology-enabled ecosystem for protection and insurance. The platform provides a comprehensive range of offerings, including device protection, travel, motor, property, life insurance, and digital insurance, catering to the needs of consumers. By leveraging digital and data-driven capabilities, bolttech facilitates connections between insurers, distributors, and customers, streamlining the process of buying and selling insurance and protection products. The company is focused on expanding its presence internationally, particularly in Asia, to enhance accessibility and efficiency in the insurance market.

Konfio

Series E in 2021
Konfio is a financial services platform based in Mexico City that focuses on providing online financial solutions for small and medium-sized enterprises (SMEs) and micro-entrepreneurs. Founded in 2013, the company offers a range of products including fixed-rate loans, working capital loans, corporate credit cards, and payment solutions, as well as life insurance and personal debt transfer services. Konfio utilizes a proprietary algorithm that leverages data and technology to assess creditworthiness, enabling access to credit for clients who have been underserved by traditional banking. By offering competitive rates and convenient services, Konfio aims to enhance the growth and productivity of SMEs in Mexico.

Nubank

Series G in 2021
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil

Series D in 2021
Phil, Inc. is a healthcare technology company that specializes in prescription management services aimed at improving patient access to medications. Founded in 2015 and headquartered in San Francisco, the company operates a specialty Rx distribution platform that facilitates the seamless management of medications by automatically refilling prescriptions based on established cadences. Acting as a liaison among patients, prescribers, manufacturers, and pharmacists, Phil enhances the medication access process while offering complimentary home delivery services. The platform aims to remove barriers to medication access, ensuring that patients can start and adhere to their therapies effectively. By providing end-to-end visibility into the prescription life cycle, Phil maximizes reimbursement opportunities for pharmaceutical brands and enhances patient outcomes in the management of specialty drugs.

Yieldstreet

Series C in 2021
Yieldstreet is a management platform that provides retail investors access to income-generating investment products. Founded in 2015, It gives individuals access to alternative investments that have traditionally been off-limits to the average investor. With over $2.5 billion invested across multiple asset classes, Yieldstreet is changing the way people generate passive income by lowering and removing the barriers that historically kept these lucrative opportunities far out of reach. In 2013, founders Milind Mehere and Michael Weisz were frustrated that many investment strategies were typically reserved only for institutions and the ultra-wealthy. Typically, the average investor was left to choose between the stock market and bonds with falling yields - with few options in between. Asset-based investments had longer hold periods and a higher barrier of entry, keeping them well out of reach of accredited investors — even more so for unaccredited investors. As a result, they decided to leverage the growing fintech disruption to give more people access to these previously restricted alternative investments. Milind’s background in building companies combined with Michael’s decade-plus experience in investing and fund management formed the core of Yieldstreet. Passion for their investors and employees as well as a willing embrace of innovation, has been part of Yieldstreet’s identity from the beginning. Each decision to leverage a new technology, or investment strategy, or originate a new deal is made to put investors first. That drive has propelled Yieldstreet across all 50 states, crossing $100M invested in less than eight quarters, with the $1B milestone coming only three years later. In 2019, Yieldstreet’s membership had grown to 100,000, and a savings account for members was launched. Yieldstreet, since its launch in 2015, has not deviated from its goal to change investing for the better, nor has it slowed down. Yieldstreet was ranked number 46 on the Inc. 5000 list of the fastest-growing companies and has been recognized by Built In as one of the Best Places to Work. Yieldstreet today delivers wealth generation options and alternative investments for more than 330,000 investors and has returned more than $1.3 billion in principal/interest. Many alternative investment platforms only focus on one asset class, such as real estate or art. Yieldstreet’s offerings, accessed through cash or a low-fee IRA, cover a wide range of asset classes — art, real estate, legal, corporates, consumer, and commercial, via single investments or funds. Yieldstreet also offers its members short-term notes on offerings with a hold period between 3 and 6 months, which generally boast higher interest rates than money markets and CDs. Yieldstreet is headquartered in New York and has offices in Brazil, Greece, and Malta. Michael Weisz serves as President and Milind Mehere serves as CEO. Together, they manage a team of more than 140 employees, all working toward Yieldstreet’s one goal: to change the way people invest for the better.

Phil

Series C in 2021
Phil, Inc. is a healthcare technology company that specializes in prescription management services aimed at improving patient access to medications. Founded in 2015 and headquartered in San Francisco, the company operates a specialty Rx distribution platform that facilitates the seamless management of medications by automatically refilling prescriptions based on established cadences. Acting as a liaison among patients, prescribers, manufacturers, and pharmacists, Phil enhances the medication access process while offering complimentary home delivery services. The platform aims to remove barriers to medication access, ensuring that patients can start and adhere to their therapies effectively. By providing end-to-end visibility into the prescription life cycle, Phil maximizes reimbursement opportunities for pharmaceutical brands and enhances patient outcomes in the management of specialty drugs.

BYJU'S

Series F in 2021
BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing engaging and effective learning solutions to over 150 million students worldwide. Its mission focuses on making high-quality education accessible, with a diverse range of offerings that include BYJU's: The Learning App and other brands like Disney-BYJU's Early Learn and BYJU's FutureSchool. The company's platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a personalized educational experience that adapts to each student's unique learning style and pace. With a team of over 12,000 teachers, BYJU'S supports pre-K–12 education and various competitive exams, employing innovative methods that enhance engagement. The company has established partnerships with major firms such as Disney and Google to expand its reach and impact. Headquartered in India, BYJU'S operates in more than 21 countries, offering learning programs in over eight languages, and has made significant acquisitions to broaden its educational footprint.

Loft

Series D in 2021
Loft is a transactional marketplace for residential real estate based in São Paulo, Brazil, founded in 2018 by experienced entrepreneurs. It facilitates the buying and selling of properties for individuals, brokers, and publicly listed REITs, providing an end-to-end digital workflow that modernizes the homebuying experience. The platform includes a searchable database that allows users to find, browse, and evaluate residential and commercial properties, enhancing transparency in real estate transactions. By utilizing proprietary transaction data, Loft integrates various adjacent services, aiming to streamline the entire real estate process and adapt it to the e-commerce landscape.

Brightvine

Seed Round in 2021
Brightvine is a developer of a blockchain-powered platform that aims to enhance the efficiency and accessibility of the structured finance market. By combining decentralized finance (DeFi) with the global fixed-income market, Brightvine is digitizing traditional financial assets through a compliant infrastructure that allows for the tokenization of fixed-income products. This innovative approach not only facilitates faster and more cost-effective asset transactions but also opens up new investment opportunities for Web3 investors and creates additional sources of liquidity for institutional clients.

Igneo

Seed Round in 2021
Igneo specializes in e-waste recycling, focusing on converting low-grade electronic waste into sustainable metal concentrates. By utilizing patented multi-hearth technology, the company achieves a recovery rate of 98% for precious metals from e-waste, significantly surpassing traditional recycling methods. This innovative approach not only provides a cleaner and more efficient alternative to conventional mining and metal recycling but also addresses environmental concerns by reducing harmful emissions associated with precious metal recovery. Igneo's closed-loop model involves collaboration with original equipment manufacturers and smelters, further enhancing the sustainability of its operations. Through its services, Igneo aims to offer a responsible solution to the growing issue of electronic waste.

Creditas

Series E in 2020
Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

Cue

Series C in 2020
Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep. Consumers can track five key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. The Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.

Nubank

Series F in 2019
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil

Series B in 2019
Phil, Inc. is a healthcare technology company that specializes in prescription management services aimed at improving patient access to medications. Founded in 2015 and headquartered in San Francisco, the company operates a specialty Rx distribution platform that facilitates the seamless management of medications by automatically refilling prescriptions based on established cadences. Acting as a liaison among patients, prescribers, manufacturers, and pharmacists, Phil enhances the medication access process while offering complimentary home delivery services. The platform aims to remove barriers to medication access, ensuring that patients can start and adhere to their therapies effectively. By providing end-to-end visibility into the prescription life cycle, Phil maximizes reimbursement opportunities for pharmaceutical brands and enhances patient outcomes in the management of specialty drugs.

Fathom

Venture Round in 2019
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Overseas Network

Seed Round in 2019
Overseas Network is a vast large network committed to giving insider info to travel experts for all traveller needs.

Metallica Commodities

Private Equity Round in 2019
Metallica Commodities engages in the trading of metals and minerals, focusing on both non-ferrous and ferrous materials. The company is notable for operating the world's first industrial facility dedicated to recycling printed circuit boards, highlighting its commitment to innovative recycling practices. In addition to its recycling efforts, Metallica Commodities is involved in mineral asset development, with projects located in countries such as Guyana, Uganda, Tanzania, and the Democratic Republic of the Congo. The company also processes aggregates and dimension stones, contributing to its diverse portfolio in the mining and materials sector.

Cue

Series B in 2018
Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep. Consumers can track five key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. The Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.

Envisics

Seed Round in 2018
Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, focused on designing and developing advanced holographic projection systems and computational algorithms for head-up displays and head-mounted display applications. Established in 2009, Envisics specializes in light manipulation through phase-only holography, offering high-quality image projection that enhances the in-car experience. By leveraging holography and laser-based light sources, the company aims to transform automotive displays and improve safety for drivers. Through collaborations with leading automakers and tier-one suppliers, Envisics is working to bring innovative holographic technology to the automotive sector, enabling drivers to access critical information without distraction by seamlessly overlaying data onto their field of vision.

Nvoicepay

Series F in 2016
Nvoicepay is a fintech platform that delivers strategic payment solutions to automate accounts payable. They enable customers to pay 100% of their invoices electronically while realizing the financial benefits of payment optimization. It streamlines the way companies pay their accounts payable invoices through electronic payments. By paying the right suppliers with the right payment type at the right time, their cloud-based technology and vendor payment services help customers reduce costs, increase efficiencies, and maximize card rebates, all with minimal effort. They offer an intelligence-driven payment automation solution purpose-built for the most complex enterprises.

Asana BioSciences

Seed Round in 2014
Asana BioSciences, LLC is a clinical-stage biopharmaceutical company based in Bridgewater, New Jersey, focused on the discovery and development of novel targeted therapies. Operating as a subsidiary of Amneal Pharmaceuticals, the firm specializes in research related to oncology, inflammation, immunology, and pain management. Asana BioSciences aims to advance multiple early-stage drug candidates through its development pipelines, enabling collaboration with partners to enhance the potential for successful commercialization of new treatment options. Through its innovative approach, the company seeks to provide effective therapies that can benefit both physicians and patients in addressing unmet medical needs.

DAQRI

Private Equity Round in 2013
DAQRI LLC specializes in augmented reality solutions, offering a range of products designed to enhance workplace efficiency and safety. The company's flagship offerings include the DAQRI Worksense platform and DAQRI Smart Glasses, which connect digital content to the real world, allowing users to overlay information onto their physical environment. Additionally, DAQRI provides 4D Studio, a web-based tool for creating and managing augmented reality experiences, catering to storytellers, marketers, and educators. The company also develops industrial applications such as hands-free training, maintenance instructions, and real-time quality assurance systems. DAQRI's innovative solutions serve various sectors, including aerospace, healthcare, manufacturing, and education, facilitating improved productivity and communication. Established in 2007 and headquartered in Los Angeles, California, DAQRI operates sales offices across several major cities in the United States.

Prolong Pharmaceuticals

Seed Round in 2009
Prolong Pharmaceuticals, LLC is a biopharmaceutical company focused on developing products for hematology and oncology diseases. It is known for SANGUINATE, an investigational product designed to enhance oxygen delivery to cells and tissues, particularly addressing the complications associated with sickle cell disease and other conditions related to anemia or hypoxia. The company also works on ANF-Rho, which aims to create a novel molecule with a unique mechanism of action, and EPEG, a PEGylated erythropoietin biologic intended for treating anemia. Additionally, Prolong Pharmaceuticals is developing PP-403, a novel cytokine with potential applications in cancer treatment. Founded in 2002 and based in South Plainfield, New Jersey, the company engages in improving patient quality of life through innovative therapeutic solutions.
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company engaged in the development, licensing, manufacturing, marketing, and distribution of generic and specialty pharmaceutical products. It operates in three segments: Generics, Specialty, and AvKARE. The Generics segment focuses on a broad range of dosage forms, including complex oral solids, injectables, and topicals, catering to various therapeutic areas. The Specialty segment develops and sells branded pharmaceuticals primarily for central nervous system disorders and endocrinology, with notable products such as Rytary for Parkinson's Disease and Zomig for migraines. The AvKARE segment specializes in providing pharmaceuticals and medical products to governmental agencies, including re-packaging and wholesale distribution. Amneal's products are distributed through wholesalers, distributors, hospitals, and pharmacies, with operations spanning the United States, India, Ireland, and other international markets. Founded in 2002 and headquartered in Bridgewater, New Jersey, Amneal Pharmaceuticals was previously known as Atlas Holdings, Inc. until its name change in 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.